Answers are grounded in this paper and cite their sources.
Explores GSK3-targeted therapies for Alzheimer’s, indicating a new approach to disease management.
Alzheimer’s disease (AD) is a progressive neurological disorder that affects memory, thinking, and behavior. It is one of the leading causes of dementia worldwide, and current treatments mainly focus on managing symptoms rather than slowing or stopping disease progress
No takes yet. Share an insight, caveat, or question.
Krina Patel (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: